Development Plan

2019

Preclinical Studies Completion

We expect to complete preclinical studies for LGM2605 in 2019

2020

Submit IND Application to FDA

LignaMed plans to submit an IND in 2020

2022

Clinical Studies Completed and NDA Filed with FDA

LignaMed plans to complete clinical studies in 2022 and file NDA

2023

FDA Approval & Product Launch